A carregar...
Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target
Targeted therapeutics, such as those abrogating hypoxia inducible factor (HIF)/vascular endothelial growth factor signaling, are initially effective against kidney cancer (or renal cell carcinoma, RCC); however, drug resistance frequently occurs via subsequent activation of alternative pathways. Thr...
Na minha lista:
| Publicado no: | Oncogene |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5926797/ https://ncbi.nlm.nih.gov/pubmed/28166200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2016.510 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|